Hemorrhage, Gastrointestinal Completed Phase 4 Trials for Ceftriaxone (DB01212)

Also known as: Gastrointestinal haemorrhages / Gastrointestinal haemorrhage / Gastrointestinal Hemorrhage / Gastro Intestinal Bleeding / GI bleeding / Hemorrhage gastrointestinal / Gastric hemorrhage NOS / Gastrointestinal bleeding / Gastrointestinal tract bleed (NOS) / Gastrointestinal tract bleed NOS / GI haemorrhage / GI hemorrhage / Haemorrhage gastrointestinal / GI bleed / Gastrointestinal haemorrhage NOS / Gastro-intestinal tract bleed / Haemorrhage of digestive tract / Haemorrhage of gastrointestinal tract, unspecified / Hemorrhage of gastrointestinal tract, unspecified / Gastro intestinal bleed / Bleeding gastrointestinal / Gastrointestinal bleed / GI tract bleed / Hemorrhage of digestive tract

IndicationStatusPhase
DBCOND0085396 (Hemorrhage, Gastrointestinal)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00838864Comparison of 3 Days and 7 Days Intravenous Ceftriaxone Prophylaxis for Variceal BleedingPrevention